591 related articles for article (PubMed ID: 34814924)
21. Causal effect of atrial fibrillation on pulmonary embolism: a mendelian randomization study.
Liu G; Chen T; Zhang X; Hu B; Shi H
J Thromb Thrombolysis; 2024 Feb; 57(2):212-219. PubMed ID: 37839022
[TBL] [Abstract][Full Text] [Related]
22. Mendelian randomization as an approach to assess causal effects of inflammatory bowel disease on atrial fibrillation.
Chen L; Fu G; Jiang C
Aging (Albany NY); 2021 Apr; 13(8):12016-12030. PubMed ID: 33824227
[TBL] [Abstract][Full Text] [Related]
23. Associations of 50 modifiable risk factors with atrial fibrillation using Mendelian randomization analysis.
Zhang Z; Li L; Zhang Z; Hu Z; Xiong Y; Zhou L; Yao Y
Eur J Clin Invest; 2024 Jun; 54(6):e14194. PubMed ID: 38438337
[TBL] [Abstract][Full Text] [Related]
24. A phenome-wide bidirectional Mendelian randomization analysis of atrial fibrillation.
Wang Q; Richardson TG; Sanderson E; Tudball MJ; Ala-Korpela M; Davey Smith G; Holmes MV
Int J Epidemiol; 2022 Aug; 51(4):1153-1166. PubMed ID: 35292824
[TBL] [Abstract][Full Text] [Related]
25. Type 2 Diabetes and Atrial Fibrillation: Evaluating Causal and Pleiotropic Pathways Using Mendelian Randomization.
Reddy RK; Ardissino M; Ng FS
J Am Heart Assoc; 2023 Sep; 12(17):e030298. PubMed ID: 37609985
[TBL] [Abstract][Full Text] [Related]
26. No causal association between plasma homocysteine levels and atrial fibrillation: A Mendelian randomization study.
Sun X; Lu Y; Wang Z; Wang Q; Zheng L
Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):587-591. PubMed ID: 33250370
[TBL] [Abstract][Full Text] [Related]
27. Body Mass Index and the Risk of Atrial Fibrillation: A Mendelian Randomization Study.
Ma M; Zhi H; Yang S; Yu EY; Wang L
Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565843
[TBL] [Abstract][Full Text] [Related]
28. Plasma Cortisol and Risk of Atrial Fibrillation: A Mendelian Randomization Study.
Larsson SC; Lee WH; Burgess S; Allara E
J Clin Endocrinol Metab; 2021 Jun; 106(7):e2521-e2526. PubMed ID: 33822969
[TBL] [Abstract][Full Text] [Related]
29. Obstructive sleep apnea and atrial fibrillation: insights from a bidirectional Mendelian randomization study.
Chen L; Sun X; He Y; Lu Y; Zheng L
BMC Med Genomics; 2022 Feb; 15(1):28. PubMed ID: 35172829
[TBL] [Abstract][Full Text] [Related]
30. Serum albumin and atrial fibrillation: insights from epidemiological and mendelian randomization studies.
Liao LZ; Zhang SZ; Li WD; Liu Y; Li JP; Zhuang XD; Liao XX
Eur J Epidemiol; 2020 Feb; 35(2):113-122. PubMed ID: 31741136
[TBL] [Abstract][Full Text] [Related]
31. Disentangling the association between kidney function and atrial fibrillation: a bidirectional Mendelian randomization study.
Geurts S; van der Burgh AC; Bos MM; Ikram MA; Stricker BHC; Deckers JW; Hoorn EJ; Chaker L; Kavousi M
Int J Cardiol; 2022 May; 355():15-22. PubMed ID: 35278573
[TBL] [Abstract][Full Text] [Related]
32. The Risk of Atrial Fibrillation Increases with Earlier Onset of Obesity: A Mendelian Randomization Study.
Zhou Y; Zha L; Pan S
Int J Med Sci; 2022; 19(9):1388-1398. PubMed ID: 36035367
[No Abstract] [Full Text] [Related]
33. Causal effects of plasma lipids on the risk of atrial fibrillation: A multivariable mendelian randomization study.
Jiang Q; Qin D; Yang L; Lin Y; Zhai L; Zhang Y; Yang G; Wang K; Tong D; Li X; Chen Z; Huang K; Yu T; Xiang X; Cui C; Cai C; Shi J; Li M; Chen M
Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1569-1578. PubMed ID: 33814236
[TBL] [Abstract][Full Text] [Related]
34. Major depression disorder may causally associate with the increased atrial fibrillation risk: evidence from two-sample mendelian randomization analyses.
Wang L; Ding C
BMC Med Genomics; 2023 Jun; 16(1):144. PubMed ID: 37353760
[TBL] [Abstract][Full Text] [Related]
35. Genetic associations of adult height with risk of cardioembolic and other subtypes of ischemic stroke: A mendelian randomization study in multiple ancestries.
Linden AB; Clarke R; Hammami I; Hopewell JC; Guo Y; Whiteley WN; Lin K; Turnbull I; Chen Y; Yu C; Lv J; Offer A; Bennett D; Walters RG; Li L; Chen Z; Parish S;
PLoS Med; 2022 Apr; 19(4):e1003967. PubMed ID: 35452448
[TBL] [Abstract][Full Text] [Related]
36. Use of Mendelian randomization to evaluate the effect of atrial fibrillation on cardiovascular diseases and cardiac death.
Hu M; Tan J; Yang J; Gao X; Yang Y
ESC Heart Fail; 2023 Feb; 10(1):628-636. PubMed ID: 36404673
[TBL] [Abstract][Full Text] [Related]
37. Associations of lipids and lipid-modifying drug target genes with atrial fibrillation risk based on genomic data.
Tao Y; Wang Y; Yin Y; Zhang K; Gong Y; Ying H; Jiang R
Lipids Health Dis; 2024 Jun; 23(1):175. PubMed ID: 38851763
[TBL] [Abstract][Full Text] [Related]
38. Genetically predicted dietary macronutrient intakes and atrial fibrillation risk: a Mendelian randomization study.
Zhang Z; Zhang J; Jiao H; Tian W; Zhai X
Eur J Med Res; 2024 Apr; 29(1):227. PubMed ID: 38609963
[TBL] [Abstract][Full Text] [Related]
39. Genetics of height and risk of atrial fibrillation: A Mendelian randomization study.
Levin MG; Judy R; Gill D; Vujkovic M; Verma SS; Bradford Y; ; Ritchie MD; Hyman MC; Nazarian S; Rader DJ; Voight BF; Damrauer SM
PLoS Med; 2020 Oct; 17(10):e1003288. PubMed ID: 33031386
[TBL] [Abstract][Full Text] [Related]
40. Circulating interleukins in relation to coronary artery disease, atrial fibrillation and ischemic stroke and its subtypes: A two-sample Mendelian randomization study.
Yuan S; Lin A; He QQ; Burgess S; Larsson SC
Int J Cardiol; 2020 Aug; 313():99-104. PubMed ID: 32223966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
